Last updated on October 2018

Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma


Brief description of study

This study seeks to evaluate the tolerability, pharmacokinetics (PK), efficacy, and safety of ABT-414 in Japanese participants with newly diagnosed and recurrent, World Health Organization (WHO) grade III or IV malignant glioma.

Clinical Study Identifier: NCT02590263

Contact Investigators or Research Sites near you

Start Over

AbbVie GK Clinical Trial Registration ...

Nagoya University Hospital /ID# 138559
Nagoya-shi, Japan
9.11miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.